Uncovering a new role for peroxidase enzymes as drivers of angiogenesis

International Journal of Biochemistry and Cell Biology

Volumn 68, Issue , 2015, Pages 128-138

  Panagopoulos, Vasilios ^a   Zinonos, Irene ^a   Leach, Damien A ^a   Hay, Shelley J ^a   Liapis, Vasilios ^a   Zysk, Aneta ^a   Ingman, Wendy V ^a   DeNichilo, Mark O ^a   Evdokiou, Andreas ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Digestive Disease Research Centre   (Australia)

Author keywords

Angiogenesis; Eosinophil peroxidase; Inflammation; Myeloperoxidase

Indexed keywords

ALPHA4 INTEGRIN; ANGIOPOIETIN 2; CD44V ANTIGEN; COLLAGEN TYPE 4; EOSINOPHIL PEROXIDASE; FOCAL ADHESION KINASE 1; FOLLISTATIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYELOPEROXIDASE; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE B; SPHINGOSINE 1 PHOSPHATE RECEPTOR; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN D; 4-AMINOBENZHYDRAZIDE; ANILINE DERIVATIVE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; COLLAGEN; DRUG COMBINATION; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; ENZYME INHIBITOR; LAMININ; MAPK1 PROTEIN, HUMAN; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXIDASE; PROTEOGLYCAN; PTK2 PROTEIN, HUMAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; REGULATORY MECHANISM; TISSUE REGENERATION; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOASSAY; CELL MOTION; CHEMISTRY; CYTOLOGY; DRUG COMBINATION; DRUG EFFECTS; ENDOCYTOSIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION;

ANILINE COMPOUNDS; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOLOGICAL ASSAY; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; ENDOCYTOSIS; ENZYME INHIBITORS; EOSINOPHIL PEROXIDASE; FEMALE; FOCAL ADHESION KINASE 1; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAMININ; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PHYSIOLOGIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXIDASE; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84943248400     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2015.09.006     Document Type: Article

References (65)

1. R.I. Abu-Ghazaleh, S.L. Dunnette, D.A. Loegering, J.L. Checkel, H. Kita, L.L. Thomas, and G.J. Gleich Eosinophil granule proteins in peripheral blood granulocytes J. Leukoc. Biol. 52 1992 611 618
2. N.S. Azad, E.M. Posadas, V.E. Kwitkowski, S.M. Steinberg, L. Jain, C.M. Annunziata, L. Minasian, G. Sarosy, H.L. Kotz, A. Premkumar, L. Cao, D. McNally, C. Chow, H.X. Chen, J.J. Wright, W.D. Figg, and E.C. Kohn Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity J. Clin. Oncol. 26 2008 3709 3714
3. E.L. Bell, T.A. Klimova, J. Eisenbart, P.T. Schumacker, and N.S. Chandel Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia Mol. Cell. Biol. 27 2007 5737 5745
4. G. Bergers, and D. Hanahan Modes of resistance to anti-angiogenic therapy Nat. Rev. Cancer 8 2008 592 603
5. R.D. Blumenthal, M. Samoszuk, A.P. Taylor, G. Brown, R. Alisauskas, and D.M. Goldenberg Degranulating eosinophils in human endometriosis Am. J. Pathol. 156 2000 1581 1588
6. E. Bonanno, M. Iurlaro, J.A. Madri, and R.F. Nicosia Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model In Vitro Cell. Dev. Biol. Anim. 36 2000 336 340
7. A. Bos, R. Wever, and D. Roos Characterization and quantification of the peroxidase in human monocytes Biochim. Biophys. Acta 525 1978 37 44
8. P. Carmeliet Angiogenesis in life, disease and medicine Nature 438 2005 932 936
9. N.S. Chandel, E. Maltepe, E. Goldwasser, C.E. Mathieu, M.C. Simon, and P.T. Schumacker Mitochondrial reactive oxygen species trigger hypoxia-induced transcription Proc. Natl. Acad. Sci. U.S.A. 95 1998 11715 11720
10. A. Churg, C.V. Marshall, D.D. Sin, S. Bolton, S. Zhou, K. Thain, E.B. Cadogan, J. Maltby, M.G. Soars, P.R. Mallinder, and J.L. Wright Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 185 2012 34 43
11. M.J. Davies, C.L. Hawkins, D.I. Pattison, and M.D. Rees Mammalian heme peroxidases: from molecular mechanisms to health implications Antioxid. Redox Signal. 10 2008 1199 1234
12. M. DeNichilo, V. Panagopoulos, T. Rayner, R. Borowicz, J. Greenwood, and A. Evdokiou Peroxidase enzymes regulate collagen extracellular matrix biosynthesis Am. J. Pathol. 185 2015 1372 1384
13. D.C. Felmeden, A.D. Blann, and G.Y. Lip Angiogenesis: basic pathophysiology and implications for disease Eur. Heart J. 24 2003 586 603
14. P.T. Flood-Page, A.N. Menzies-Gow, A.B. Kay, and D.S. Robinson Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway Am. J. Respir. Crit. Care Med. 167 2003 199 204
15. K.C. Foy, Z. Liu, G. Phillips, M. Miller, and P.T.P. Kaumaya Combination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivo J. Biol. Chem. 286 2011 13626 13637
16. R.S. Frey, M. Ushio-Fukai, and A.B. Malik NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology Antioxid. Redox Signal. 11 2009 791 810
17. S. Gross, S.T. Gammon, B.L. Moss, D. Rauch, J. Harding, J.W. Heinecke, L. Ratner, and D. Piwnica-Worms Bioluminescence imaging of myeloperoxidase activity in vivo Nat. Med. 15 2009 455 461
18. K. Helczynska, A.-M. Larsson, L. Holmquist Mengelbier, E. Bridges, E. Fredlund, S. Borgquist, G. Landberg, S. Pahlman, and K. Jirstrom Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer Cancer Res. 68 2008 9212 9220
19. A. Hoeben, B. Landuyt, M.S. Highley, H. Wildiers, A.T. Van Oosterom, and E.A. De Bruijn Vascular endothelial growth factor and angiogenesis Pharmacol. Rev. 56 2004 549 580
20. L. Holmquist-Mengelbier, E. Fredlund, T. Lofstedt, R. Noguera, S. Navarro, H. Nilsson, A. Pietras, J. Vallon-Christersson, A. Borg, K. Gradin, L. Poellinger, and S. Pahlman Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype Cancer Cell 10 2006 413 423
21. D.W. Huang, B.T. Sherman, and R.A. Lempicki Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists Nucleic Acids Res. 37 2009 1 13
22. D.W. Huang, B.T. Sherman, and R.A. Lempicki Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 4 2009 44 57
23. E. Kaczmarek, L. Erb, K. Koziak, R. Jarzyna, M.R. Wink, O. Guckelberger, J.K. Blusztajn, V. Trinkaus-Randall, G.A. Weisman, and S.C. Robson Modulation of endothelial cell migration by extracellular nucleotides: involvement of focal adhesion kinase and phosphatidylinositol 3-kinase-mediated pathways Thromb. Haemost. 93 2005 735 742
24. A.J. Kettle, C.A. Gedye, and C.C. Winterbourn Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide Biochem. J. 321 1997 503 508
25. Y.W. Kim, X.Z. West, and T.V. Byzova Inflammation and oxidative stress in angiogenesis and vascular disease J. Mol. Med. (Berl.) 91 2013 323 328
26. S.J. Klebanoff Myeloperoxidase Proc. Assoc. Am. Phys. 111 1999 383 389
27. S.J. Klebanoff Myeloperoxidase: friend and foe J. Leukoc. Biol. 77 2005 598 625
28. A. Klinke, C. Nussbaum, L. Kubala, K. Friedrichs, T.K. Rudolph, V. Rudolph, H.-J. Paust, C. Schroder, D. Benten, D. Lau, K. Szocs, P.G. Furtmuller, P. Heeringa, K. Sydow, H.-J. Duchstein, H. Ehmke, U. Schumacher, T. Meinertz, M. Sperandio, and S. Baldus Myeloperoxidase attracts neutrophils by physical forces Blood 117 2011 1350 1358
29. E. Kolaczkowska, and P. Kubes Phagocytes & granulocytes. Angiogenic neutrophils: a novel subpopulation paradigm Blood 120 2012 4455 4457
30. D. Lau, and S. Baldus Myeloperoxidase and its contributory role in inflammatory vascular disease Pharmacol. Ther. 111 2006 16 26
31. D.A. Leach, E.F. Need, A.P. Trotta, M.J. Grubisha, D.B. DeFranco, and G. Buchanan Hic-5 influences genomic and non-genomic actions of the androgen receptor in prostate myofibroblasts Mol. Cell. Endocrinol. 384 2014 185 199
32. D. Liao, and R.S. Johnson Hypoxia: a key regulator of angiogenesis in cancer Cancer Metastasis Rev. 26 2007 281 290
33. H. Lu, W. Ouyang, and C. Huang Inflammation, a key event in cancer development Mol. Cancer Res. 4 2006 221 233
34. T. Maffucci, E. Piccolo, A. Cumashi, M. Iezzi, A.M. Riley, A. Saiardi, H.Y. Godage, C. Rossi, M. Broggini, S. Iacobelli, B.V. Potter, P. Innocenti, and M. Falasca Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects Cancer Res. 65 2005 8339 8349
35. P.H. Maxwell The HIF pathway in cancer Semin. Cell Dev. Biol. 16 2005 523 530
36. D.M. McDonald Angiogenesis and remodeling of airway vasculature in chronic inflammation Am. J. Respir. Crit. Care Med. 164 2001 S39 S45
37. K.L. Meadows, and H.I. Hurwitz Anti-VEGF therapies in the clinic Cold Spring Harb. Perspect. Med. 2 2012
38. A.N. Moor, D.J. Vachon, and L.J. Gould Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers Wound Repair Regen. 17 2009 832 839
39. J. Papakrivopoulou, G.E. Lindahl, J.E. Bishop, and G.J. Laurent Differential roles of extracellular signal-regulated kinase 1/2 and p38MAPK in mechanical load-induced procollagen alpha1(I) gene expression in cardiac fibroblasts Cardiovasc. Res. 61 2004 736 744
40. M. Parri, L. Pietrovito, A. Grandi, S. Campagnoli, E. De Camilli, F. Bianchini, S. Marchio, F. Bussolino, B. Jin, P. Sarmientos, G. Grandi, G. Viale, P. Pileri, P. Chiarugi, and R. Grifantini Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer Angiogenesis 17 2014 881 896
41. A. Passaniti, R.M. Taylor, R. Pili, Y. Guo, P.V. Long, J.A. Haney, R.R. Pauly, D.S. Grant, and G.R. Martin A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor Lab. Invest. 67 1992 519 528
42. E.K. Patterson, D.D. Fraser, A. Capretta, R.F. Potter, and G. Cepinskas Carbon monoxide-releasing molecule 3 inhibits myeloperoxidase (MPO) and protects against MPO-induced vascular endothelial cell activation/dysfunction Free Radic. Biol. Med. 70 2014 167 173
43. A. Pietras, A.S. Johnsson, and S. Pahlman The HIF-2alpha-driven pseudo-hypoxic phenotype in tumor aggressiveness, differentiation, and vascularization Curr. Top. Microbiol. Immunol. 345 2010 1 20
44. C.W. Pugh, and P.J. Ratcliffe Regulation of angiogenesis by hypoxia: role of the HIF system Nat. Med. 9 2003 677 684
45. I. Puxeddu, A. Alian, A.M. Piliponsky, D. Ribatti, A. Panet, and F. Levi-Schaffer Human peripheral blood eosinophils induce angiogenesis Int. J. Biochem. Cell Biol. 37 2005 628 636
46. S. Rousseau, F. Houle, J. Landry, and J. Huot p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells Oncogene 15 1997 2169 2177
47. A.L. Rymaszewski, E. Tate, J.P. Yimbesalu, A.E. Gelman, J.A. Jarzembowski, H. Zhang, K.A. Pritchard Jr., and H.G. Vikis The role of neutrophil myeloperoxidase in models of lung tumor development Cancers 6 2014 1111 1127
48. M. Samoszuk, F. Lin, P. Rim, and G. Strathearn New marker for blood vessels in human ovarian and endometrial cancers Clin. Cancer Res. 2 1996 1867 1871
49. M.K. Samoszuk, V. Nguyen, I. Gluzman, and J.H. Pham Occult deposition of eosinophil peroxidase in a subset of human breast carcinomas Am. J. Pathol. 148 1996 701 706
50. C.-S. Shi, G.-Y. Shi, Y.-S. Chang, H.-S. Han, C.-H. Kuo, C. Liu, H.-C. Huang, Y.-J. Chang, P.-S. Chen, and H.-L. Wu Evidence of human thrombomodulin domain as a novel angiogenic factor Circulation 111 2005 1627 1636
51. T. Shih, and C. Lindley Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies Clin. Ther. 28 2006 1779 1802
52. N. Sivamurthy, D.H. Stone, F.W. LoGerfo, and W.C. Quist Apolipoprotein J inhibits the migration and adhesion of endothelial cells Surgery 130 2001 204 209
53. N. Skuli, L. Liu, A. Runge, T. Wang, L. Yuan, S. Patel, L. Iruela-Arispe, M.C. Simon, and B. Keith Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis Blood 114 2009 469 477
54. Z. Szekanecz, and A.E. Koch Mechanisms of disease: angiogenesis in inflammatory diseases Nat. Clin. Prac. Rheumatol. 3 2007 635 643
55. Y.R. Tahboub, S. Galijasevic, M.P. Diamond, and H.M. Abu-Soud Thiocyanate modulates the catalytic activity of mammalian peroxidases J. Biol. Chem. 280 2005 26129 26136
56. P. Taylor The angiogenic drive in chronic inflammation: hypoxia and the cytokine milieu M. Seed, D. Walsh, Angiogenesis in Inflammation: Mechanisms and Clinical Correlates 2008 Birkhäuser Basel Birkhäuser, Birkhäuser 15 28
57. R.M. Ten, L.R. Pease, D.J. McKean, M.P. Bell, and G.J. Gleich Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family J. Exp. Med. 169 1989 1757 1769
58. B. Vailhe, D. Vittet, and J.J. Feige In vitro models of vasculogenesis and angiogenesis Lab. Invest. 81 2001 439 452
59. A.J. Weickhardt, D. Williams, C. Lee, J. Simes, C. Murone, K. Wilson, M. Cummins, K. Asadi, T.J. Price, J. Mariadason, N.C. Tebbutt, and A.G.T. Grp Vascular endothelial growth factors (VEGF) and VEGF receptor expression as predictive biomarkers for benefit with bevacizumab in metastatic colorectal cancer (mCRC): analysis of the phase III MAX study J. Clin. Oncol. 29 2011
60. S.E. Wenzel, L.B. Schwartz, E.L. Langmack, J.L. Halliday, J.B. Trudeau, R.L. Gibbs, and H.W. Chu Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics Am. J. Respir. Crit. Care Med. 160 1999 1001 1008
61. X. Xin, S. Yang, J. Kowalski, and M.E. Gerritsen Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo J. Biol. Chem. 274 1999 9116 9121
62. X. Xue, and Y.M. Shah Hypoxia-inducible factor-2alpha is essential in activating the COX2/mPGES-1/PGE2 signaling axis in colon cancer Carcinogenesis 34 2013 163 169
63. J.J. Yang, G.A. Preston, W.F. Pendergraft, M. Segelmark, P. Heeringa, S.L. Hogan, J.C. Jennette, and R.J. Falk Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants Am. J. Pathol. 158 2001 581 592
64. G. Zabucchi, M.R. Soranzo, R. Menegazzi, P. Bertoncin, E. Nardon, and P. Patriarca Uptake of human eosinophil peroxidase and myeloperoxidase by cells involved in the inflammatory process J. Histochem. Cytochem. 37 1989 499 508
65. N. Zhang, K.P. Francis, A. Prakash, and D. Ansaldi Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of near-infrared nanoparticles Nat. Med. 19 2013 500 505